(Credit: Thinkstock)

AmeriLife Group LLC has agreed to distribute a cancer DNA testing benefit program from Wamberg Genomic Advisors.

(Related: Life Insurers Could Help Clients Decode Their Tumors: Idea File)

AmeriLife is a life insurance, annuity and health insurance distributor based in Clearwater, Florida, with relationships with about 140,000 life insurance agents.

Wamberg Genomic Advisors is a La Jolla, California-based company that markets packages of DNA testing services.

AmeriLife will be offering Wamberg Genomic Advisors’ Cancer Guardian program.

The program includes access to a nurse advocacy program and a second opinion pathology review service as well as cancer DNA sequencing services.

Wamberg Genomic Advisors has been marketing the Cancer Guardian program through employee benefits product distributors.

— Read AmeriLife Acquires Majority Stake in Brookstone Capital Management, on ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on Facebook, LinkedIn and Twitter.